Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: Implications in acute myocardial infarction

Translational Research

Volumn 165, Issue 3, 2015, Pages 387-395

  Xie, Shuang Lun ^a   Chen, Yu Yang ^a   Zhang, Hai Feng ^a   Deng, Bing Qing ^a   Shu, Xiao Rong ^a   Su, Zi Zhuo ^a   Lin, Yong Qing ^a   Nie, Ru Qiong ^a   Wang, Jing Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Abbreviations; acute myocardial infarction; AMI; ECM; EMMPRIN; extracellular matrix; extracellular matrix metalloproteinase inducer; IL 18; interleukin 18; metalloproteinases; MMPs; SAP; stable angina pectoris

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CD147 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GELATINASE B; INTERLEUKIN 18; NITRIC ACID DERIVATIVE; SMALL INTERFERING RNA; BSG PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; HEART INFARCTION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANGINA PECTORIS; ANTIGENS, CD147; CASE-CONTROL STUDIES; FEMALE; GENE SILENCING; HUMANS; INTERLEUKIN-18; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION;

EID: 84924571643     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.09.001     Document Type: Article

References (37)

1. P.L. Weissberg, and M.R. Bennett Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 1928 1929
2. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
3. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365 372
4. A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
5. Z.S. Galis, M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, and P. Libby Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions Ann N Y Acad Sci 748 1995 501 507
6. H. Yamagami, K. Kitagawa, and T. Hoshi et al. Associations of serum IL-18 levels with carotid intima-media thickness Arterioscler Thromb Vasc Biol 25 2005 1458 1462
7. J. Hulthe, W. McPheat, A. Samnegard, P. Tornvall, A. Hamsten, and P. Eriksson Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6 Atherosclerosis 188 2006 450 454
8. Z. Mallat, A. Corbaz, and A. Scoazec et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability Circulation 104 2001 1598 1603
9. S. Blankenberg, L. Tiret, and C. Bickel et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina Circulation 106 2002 24 30
10. C.R. Narins, D.A. Lin, P.B. Burton, Z.G. Jin, and B.C. Berk Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction Am J Cardiol 94 2004 1285 1287
11. M. Abraham, S. Shapiro, N. Lahat, and A. Miller The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells Int Immunol 14 2002 1449 1457
12. B. Zhang, K.F. Wu, and Z.Y. Cao et al. IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression Leuk Res 28 2004 91 95
13. C. Biswas, Y. Zhang, and R. DeCastro et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res 55 1995 434 439
14. D.A. Siwik, G.M. Kuster, and J.V. Brahmbhatt et al. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes J Mol Cell Cardiol 44 2008 210 217
15. R. Schmidt, A. Bultmann, and M. Ungerer et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction Circulation 113 2006 834 841
16. Y.W. Yoon, H.M. Kwon, and K.C. Hwang et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque Atherosclerosis 180 2005 37 44
17. V.S. Reddy, S.D. Prabhu, and S. Mummidi et al. Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation Am J Physiol Heart Circ Physiol 299 2010 H1242 H1254
18. B. Venkatesan, A.J. Valente, V.S. Reddy, D.A. Siwik, and B. Chandrasekar Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration Am J Physiol Heart Circ Physiol 297 2009 H874 H886
19. H.H. Ho, T.T. Antoniv, J.D. Ji, and L.B. Ivashkiv Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1 J Immunol 181 2008 5089 5097
20. F. Mach, U. Schonbeck, and R.P. Fabunmi et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation Am J Pathol 154 1999 229 238
21. J.M. Siddesha, A.J. Valente, and S.S. Sakamuri et al. Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK J Cell Physiol 229 2013 845 855
22. D. Maugeri, C. Mamazza, and F. Lo Giudice et al. Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis Arch Gerontol Geriatr 40 2005 299 305
23. T.B. Opstad, A.A. Pettersen, H. Arnesen, and I. Seljeflot The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients PLoS One 8 2013 e74498
24. M. Wang, J. Tan, Y. Wang, K.K. Meldrum, C.A. Dinarello, and D.R. Meldrum IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction Proc Natl Acad Sci U S A 106 2009 17499 17504
25. B.J. Jefferis, P.H. Whincup, and P. Welsh et al. Prospective study of IL-18 and risk of MI and stroke in men and women aged 60-79 years: a nested case-control study Cytokine 61 2013 513 520
26. A. Turgut, N.Y. Goruk, and S.Y. Tunc et al. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in the endometrium of patients with repeated implantation failure after in vitro fertilization Eur Rev Med Pharmacol Sci 18 2014 275 280
27. M.K. Hong, G.S. Mintz, and C.W. Lee et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients Circulation 110 2004 928 933
28. K.J. Molloy, M.M. Thompson, and J.L. Jones et al. Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity Circulation 110 2004 337 343
29. D. Fukuda, K. Shimada, and A. Tanaka et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris Am J Cardiol 97 2006 175 180
30. A.C. Newby Metalloproteinases and vulnerable atherosclerotic plaques Trends Cardiovasc Med 17 2007 253 258
31. S. Xie, R. Nie, and J. Wang Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability J Postgrad Med 55 2009 284 286
32. R. Nie, S. Xie, B. Du, X. Liu, B. Deng, and J. Wang Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction Arch Med Res 40 2009 605 611
33. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
34. D.L. Brown, M.S. Hibbs, M. Kearney, C. Loushin, and J.M. Isner Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina Circulation 91 1995 2125 2131
35. N. Gerdes, G.K. Sukhova, P. Libby, R.S. Reynolds, J.L. Young, and U. Schonbeck Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis J Exp Med 195 2002 245 257
36. Z. Mallat, P. Henry, and R. Fressonnet et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes Heart 88 2002 467 469
37. M. Nold, A. Goede, W. Eberhardt, J. Pfeilschifter, and H. Muhl IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10 Naunyn Schmiedebergs Arch Pharmacol 367 2003 68 75